Peter Luo
Impact in
-
- Immune Cell Function and Interaction
Papers in
- Oncology 16
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 8
- Peptidase Inhibition and Analysis 6
- Colorectal Cancer Treatments and Studies 2
- Cancer Cells and Metastasis 2
- Immunology 10
- Immunotherapy and Immune Responses 4
- Co-authors
- Guizhong Liu (13 shared papers)Sun M. Han (1 shared paper)Arka Rao (1 shared paper)Louis Cohen (1 shared paper)Frank J. Piscotta (1 shared paper)Dominic A. Colosimo (1 shared paper)Sean F. Brady (1 shared paper)Amanda J. Pickard (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Research (4 papers)Annals of Oncology (2 papers)iScience (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Peter Luo
19 papers receiving 318 citations
Peers
Comparison fields: 5 of 73
- Biological Psychiatry 19
- Immunology 77
- Molecular Biology 185
- Oncology 72
- Cell Biology 37
Countries citing papers authored by Peter Luo
This map shows the geographic impact of Peter Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Luo more than expected).
Fields of papers citing papers by Peter Luo
This network shows the impact of papers produced by Peter Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Luo. The network helps show where Peter Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 132 | |
| 2 | 2018 | 42 | |
| 3 | 2017 | 35 | |
| 4 | 2017 | 32 | |
| 5 | 2019 | 17 | |
| 6 | 2023 | 14 | |
| 7 | 2018 | 12 | |
| 8 | 2024 | 8 | |
| 9 | 2023 | 7 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 5 | |
| 12 | 2021 | 3 | |
| 13 | 2025 | 2 | |
| 14 | 2021 | 2 | |
| 15 | 2022 | 2 | |
| 16 | 2021 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2022 | 1 |
About Peter Luo
Peter Luo is a scholar working on Oncology, Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 325 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (8 papers), Peptidase Inhibition and Analysis (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Immunotherapy and Immune Responses (4 papers), Renal and related cancers (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Biological Psychiatry (19 citations), Immunology (77 citations), Molecular Biology (185 citations), Oncology (72 citations) and Cell Biology (37 citations). Peter Luo has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Guizhong Liu, Sun M. Han, Arka Rao, Louis Cohen, Frank J. Piscotta, Dominic A. Colosimo, Sean F. Brady, Amanda J. Pickard, Michael Boyce and Justin R. Cross. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, iScience and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.